Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...

One way of assessing or assigning risk is to use a 'myocardium at risk' score. These scores help to systematically calculate the severity of CAD based on angiographic findings and also give an ...

CHICAGO, IL—Contrary to shorter-term results, follow-up beyond 4 years shows that elective intra-aortic balloon pump (IABP) therapy in high-risk patients receiving percutaneous coronary intervention ...

Major adverse cardiac and CV events were not reduced in patients with severe left ventricular dysfunction and extensive coronary disease who had an intra-aortic balloon inserted before percutaneous ...

Use of an increasingly common percutaneous coronary intervention of inserting an intra-aortic balloon pump (IABP) to improve blood flow prior to patients undergoing stent placement did not lower rates ...

PARIS -- Intra-aortic balloon pumps (IABP) didn't significantly improve outcomes for patients with ischemia persisting well after percutaneous coronary intervention (PCI) for a large acute ST-segment ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...

The intra-aortic balloon pump (IABP), while effective in adults, could be limited in effectiveness in infants because of differences in coronary dynamics, central vascular impedence, heart rate, and ...

The applicability and validity of registry data remains open to debate. When studying a patient cohort that is notoriously difficult to enroll in randomized trials, registry data can certainly add ...